Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs

25Citations
Citations of this article
179Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Histiocytic sarcoma affecting the central nervous system (CNS HS) in dogs may present as primary or disseminated disease, often characterized by inflammation. Prognosis is poor, and imaging differentiation from other CNS tumors can be problematic. Objective: To characterize the clinicopathological inflammatory features, breed predisposition, and survival in dogs with CNS HS. Animals: One hundred two dogs with HS, 62 dogs with meningioma. Methods: Retrospective case series. Records were reviewed for results of cerebrospinal fluid (CSF) analysis, CBC, treatment, and outcome data. Results: Predisposition for CNS HS was seen in Bernese Mountain Dogs, Golden Retrievers, Rottweilers, Corgis, and Shetland Sheepdogs (P ≤.001). Corgis and Shetland Sheepdogs had predominantly primary tumors; Rottweilers had exclusively disseminated tumors. Marked CSF inflammation was characteristic of primary rather than disseminated HS, and neoplastic cells were detected in CSF of 52% of affected dogs. Increased neutrophil to lymphocyte ratios were seen in all groups relative to controls (P

Cite

CITATION STYLE

APA

Toyoda, I., Vernau, W., Sturges, B. K., Vernau, K. M., Rossmeisl, J., Zimmerman, K., … Dickinson, P. J. (2020). Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs. Journal of Veterinary Internal Medicine, 34(2), 828–837. https://doi.org/10.1111/jvim.15673

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free